David-Alexandre C Gros does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., NEUROCRINE BIOSCIENCES INC, and Eledon Pharmaceuticals, Inc..

2016 was David-Alexandre C Gros's most active year for acquiring shares with 3 total transactions. David-Alexandre C Gros's most active month to acquire stocks was the month of January. 2016 saw David-Alexandre C Gros paying a total of $62,749.00 for 26,000 shares, this is the most they've acquired in one year.